Healthcare Costs and Treatment Patterns of Triplet Therapies in Relapsed/Refractory Multiple Myeloma: Real World Evidence from Italy
Valentina Perrone, Melania Leogrande, Elisa Giacomini, Maria Cappuccilli, Luca Degli Esposti On behalf of the LHU study groupCliCon S.R.L. Società Benefit, Health Economics and Outcomes Research, Bologna, ItalyCorrespondence: Valentina Perrone, CliCon S.R.L. Società Benefit - Health, Economics and O...
Saved in:
| Main Authors: | Perrone V, Leogrande M, Giacomini E, Cappuccilli M, Degli Esposti L |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-07-01
|
| Series: | ClinicoEconomics and Outcomes Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/healthcare-costs-and-treatment-patterns-of-triplet-therapies-in-relaps-peer-reviewed-fulltext-article-CEOR |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New Possibilities of Treatment for Relapsed/Refractory Multiple Myeloma: A Literature Review
by: OM Votyakova
Published: (2017-10-01) -
A Real-World Analysis of Patients with Triple Class Exposed Multiple Myeloma in Italy: Epidemiology Estimates, Treatment Pattern and Economic Burden
by: Valentina Perrone, et al.
Published: (2025-07-01) -
Efficacy of IsaPomDex triplet therapy in double refractory multiple myeloma patients in real clinical practice in Russia
by: M. V. Solovev, et al.
Published: (2024-12-01) -
Daratumumab (anti-CD38)- and elotuzumab (anti-SLAMF7)-based treatments for refractory POEMS syndrome: a single-center case series
by: Tomoki Suichi, et al.
Published: (2025-12-01) -
Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma Group
by: Jiri Minarik, et al.
Published: (2025-04-01)